Bridging Clinical Research And Real-World Evidence Acute and Post-Acute Outcomes with an Oral Option for High Risk Adults with COVID-19Industry Webcast Sponsored by Pfizer, Inc.; Not for CME/CE Credit

Learn about clinical trial data and real-world evidence associated with an oral treatment option for adults with COVID-19 at high risk for progression to severe illness.

We will also discuss how to identify high-risk patients, tools and resources to manage potential DDIs, and more.

Watch

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 7/22/2026

Expiration Date: 7/22/2026

Topics

Infectious Diseases

Faculty

Timothy Connelly, MD, MBA, FACP

Faculty

Timothy Connelly, MD, MBA, FACP

Learn More

Industry Sponsor

Pfizer, Inc.

Fine Print

Computer System Requirements

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.